Morristown, N.J.-based ImageCare Centers is unveiling its new “PINK Better Mammo” service with the addition of ProFound AI for Digital Breast Tomosynthesis (DBT). ProFound AI is an artificial intelligence (AI) software for DBT, or 3D mammography, to be U.S. FDA-cleared. It will be rolled out to all ImageCare mammography centers this October.
PINK Breast Center, the women’s health services arm of ImageCare Centers, has been using ProFound AI since September 2019. The technology has improved workflow and reading accuracy at the facility since adoption, offering benefits to both clinicians and patients, facility officials say. ProFound AI not only reduced the rate of false positives and unnecessary recalls for women, it also decreased the amount of biopsies and increased the chance the biopsies performed were needed, according to ImageCare Centers personnel.
Built with deep-learning technology, ProFound AI rapidly analyzes each DBT image, or slice, detecting malignant soft-tissue densities and calcifications. Certainty of Finding and Case Scores are assigned to each detection and each case, respectively. These scores represent the algorithm’s confidence that a detection or case is malignant, providing crucial information for radiologists that may assist them in clinical decision making.
“ProFound AI is revolutionizing the way mammography is read. With superior performance and sensitivity, the software offers unrivaled accuracy and time-savings benefits,” according to Stacey Stevens, president of iCAD, the manufacturer of ProFound AI. “As one of the latest tools in the fight against breast cancer, we are pleased that it will soon be available to more women in New Jersey.”
ProFound AI for DBT was clinically proven in a large reader study to increase radiologists’ sensitivity by 8%, minimize the rate of false positives and unnecessary recalls by 7%, and reduce reading time by 52.7%. ProFound AI was also clinically proven to slash reading time by up to 57.4% for radiologists reading cases of women with dense breasts.
“When ProFound AI highlights an area, we know it’s something to investigate. It’s much more selective than other CAD technologies and offers a remarkable improvement in terms of the focus,” says Lisa Sheppard, MD, founder of PINK Breast Center. “This technology has made a tremendous impact on patient care at PINK Breast Center. It helps to ensure that the biopsies we perform are more likely to be cancer, and we also now have fewer false positives and callbacks.”